Financial Highlights and Market Update
Near Term Focus Areas
Focus on achieving a diverse product mix offering products at various stages of their
lifecycle as well as a robust product pipeline
Commercialization of fill-finish vaccine manufacturing capacity and capability building on vaccine
drug substance manufacturing. We also look to continuing investments towards creating robust
infrastructure for the vaccine and bio-similar space
10
10
Expanding development and manufacturing capabilities in new delivery systems such as pens
and cartridges
Expanding development and manufacturing capabilities in complex injectables such as
peptides, long-acting injectables, suspensions and hormonal products
Geographic expansion in to emerging markets to diversify revenue base while maintaining
healthy profitability
GLANDView entire presentation